ArticleJournal of obstetrics and gynaecology of India2025
Effect of Single and Multiple Methotrexate Doses Treatment on Ovarian Reserve in Ectopic Pregnancy Women: A Prospective Cohort Study.
Article in Journal of obstetrics and gynaecology of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: One of the main concerns for women diagnosed with ectopic pregnancy (EP). This study has been designed to evaluate the potential effects of methotrexate (MTX) single and multi-dose exposures on the ovarian reserve. Methods: This was a prospective observational cohort study that was held in the Imam Khomeini Hospital, Ahvaz, Iran, from June 2021 to October 2022. Demographic information such as (age, body mass index (BMI), gravid, and parity) were recorded. Follicle stimulation hormone (FSH), estradiol plasma levels (on day 3 of the cycle), and Anti-Mullerian Hormone (AMH) were measured two times before MTX administration (pre-treatment) and then eight weeks after treatment (post-treatment). Also, antral follicle count (AFC) was evaluated by trans-vaginal ultrasound pre- and post-treatment. Results: One hundred and seventy-two patients were recruited into the study. There was no difference in levels of FSH, AMH and AFC between single-dose and multiple-dose groups. There was only a statistically significant difference in estradiol levels between the two groups (P: 0.02), and estradiol concentrations were higher in the multiple-dose MTX group. Conclusion: Administration of MTX (regardless of number of doses) has no negative effect on ovarian reserve and is safe to be used as a treatment for EP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.